Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
12/29/2010 | CN101926908A Chinese medicinal composition for treating cold |
12/29/2010 | CN101926900A Pediluvium composition and preparing method thereof |
12/29/2010 | CN101926893A Chinese medicament for treating appendiceal abscess |
12/29/2010 | CN101926874A Plant source bactericide and preparation method thereof |
12/29/2010 | CN101926873A Traditional Chinese medicine for treating acquired immune deficiency syndrome, and preparation method and administration method thereof |
12/29/2010 | CN101926850A Natural plant anti-dandruff spray and preparation method thereof |
12/29/2010 | CN101926846A Medicinal composition for treating pullorum disease and preparation method thereof |
12/29/2010 | CN101926840A Ultrafine powder of echinacea and preparation method and application thereof |
12/29/2010 | CN101926830A Antibacterial agent |
12/29/2010 | CN101926829A Bacillus subtillus degrading bacterial colony sensing signal and use of bacillus subtillus degrading bacterial colony as antiseptic |
12/29/2010 | CN101926828A Method for extracting antibacterial substance, water soluble polysaccharide and chitin from blaps |
12/29/2010 | CN101926824A Methods for genetic modification of hematopoietic progenitor cells and uses of the modified cells |
12/29/2010 | CN101926819A Compound polyhexamethylene guanidine complexing iodine disinfector and preparation method thereof |
12/29/2010 | CN101926804A Ceforanide C-type crystal composition for injection and preparation method thereof |
12/29/2010 | CN101926801A Medicinal composition |
12/29/2010 | CN101926796A Pharmaceutical composition for treating dog dermatomycosis, and preparation method thereof |
12/29/2010 | CN101926789A Improved topical medicaments and methods for photodynamic treatment of disease |
12/29/2010 | CN101926777A Method for preparing vidarabine monophosphate for injection |
12/29/2010 | CN101926774A Azithromycin powder composite and preparation method thereof |
12/29/2010 | CN101926758A Itraconazole suppository |
12/29/2010 | CN101926755A In-situ gel preparation of potassium dehydroandrographolide succinate and preparation method thereof |
12/29/2010 | CN101703481B Ribavirin lipid microsphere effervescent granules |
12/29/2010 | CN101658526B Veterinary compound enrofloxacin injection and preparation method thereof |
12/29/2010 | CN101623261B Cefamandole sodium proliposome preparation |
12/29/2010 | CN101565703B Eriocheir sinensis Crustin-2 gene and application of recombinant protein thereof |
12/29/2010 | CN101550151B Cefmetazole sodium compound synthetic method |
12/29/2010 | CN101519402B Thiochromone compound, synthetic method and application thereof in preparing antifungal medicaments |
12/29/2010 | CN101508978B Separation identification and purification process for chicken source H9N2 avian influenza virus strain and uses thereof |
12/29/2010 | CN101491502B Cefuroxime sodium freeze dry power preparation method |
12/29/2010 | CN101485714B Cajanus cajan leaf extract and application of monomer ingredient thereof in preparing medicament for resisting gram-positive bacteria |
12/29/2010 | CN101445504B Dioxane-2-alkyl carbamates derivatives |
12/29/2010 | CN101428114B Medicament for treating chronic hepatitis B, cirrhosis and liver ascites |
12/29/2010 | CN101422426B Nitroimidazoles medicine nano montmorillonite sustained-release agent and preparation method thereof |
12/29/2010 | CN101390825B Intra-ocular release system of voriconazole |
12/29/2010 | CN101385842B Medicine for treating chronic hepatitis b and preparation method thereof |
12/29/2010 | CN101367854B Macrolides with antibacterial activity |
12/29/2010 | CN101333526B SiRNA sequence of human cytomegalovirus UL54 gene and applications |
12/29/2010 | CN101278934B Oral soft capsule compound preparations for curing cold |
12/29/2010 | CN101249202B Medicament for preventing and treating livestock and poultry blast disease |
12/29/2010 | CN101229301B Chinese traditional medicine compounds for treating urinary system infection and prostatitis |
12/29/2010 | CN101205234B Curcumin-zinc compound as well as solid dispersion preparation and uses thereof |
12/29/2010 | CN101167805B Use of medicinal composition containing lotus leaves and hypericum japonicum total flavone extraction in preparing medicine for hepatitis B virus |
12/29/2010 | CN101166740B Imidazo (1,2-a) pyridine derivatives useful as peptide deformylase (PDF) inhibitors |
12/29/2010 | CN101130063B Segmented intestine targeted preparation of orgotein polypeptide and method of preparing the same |
12/29/2010 | CN101103029B 1,5,6-substituted-2-oxo-3-cyano-1,6a-diaza-tetrahydro-fluoranthenes as anti-infective agents |
12/29/2010 | CN101036701B Chinese traditional medicine lotion |
12/29/2010 | CN101031647B Process for producing erysipelothrix rhusiopathiae surface protective antigen mutant in escherichia coli |
12/29/2010 | CN101020053B Preparation process of inactivated rotavirus vaccine |
12/29/2010 | CA2766642A1 Compounds and methods for treating influenza |
12/29/2010 | CA2766565A1 Bispecific antibodies that bind to complement proteins |
12/29/2010 | CA2765692A1 Novel azabicyclohexanes |
12/29/2010 | CA2764526A1 The use of spinosyns and spinosyn compositions against diseases caused by protozoans, viral infections and cancer |
12/28/2010 | USRE42015 N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections |
12/28/2010 | USRE42014 Pharmaceutical compositions |
12/28/2010 | US7858824 Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing them |
12/28/2010 | US7858765 OX40R binding agents |
12/28/2010 | US7858746 recognize selectively both Programmed Death 1 (PD-1) protein and a membrane protein co-existing with PD-1 on a cell membrane, and can transmit a suppressive signal of PD-1; for medical treatment and/or prevention of diseases caused by immune abnormality |
12/28/2010 | US7858662 Medicament for the treatment of viral skin and tumour diseases |
12/28/2010 | US7858637 Administration of TLR7 ligands and prodrugs thereof for treatment of infection by hepatitis C virus |
12/28/2010 | US7858600 Non-antibiotic resistant; Gram-positive and Gram-negative bacteria; Salmonella, Streptococcus, Escherichia |
12/28/2010 | US7858595 Food, dietetic product, drugs; oligosaccharide |
12/28/2010 | US7858583 a solution of the glycopeptide derivatives containing phosphono group which acts as antibacterial agent, a polystyrene modified with divinylbenzene bead and an acidified aqueous solution ( acetic acid or HCl) of polar solvent e.g. methanol, acetonitrile, ethanol; for purification by resin chromatography |
12/28/2010 | US7858099 Method for inducing an immunological response in an animal |
12/28/2010 | US7858094 Controling abberant inflamatory response; obtain animal, incubate with modulator of inflammation, monitor animal for adjustment in inflammatory response |
12/28/2010 | US7858088 chimeric anti-EGP-2-binding scFv fragment 4D5MOC-A; for treatment of human carcinomas; Pseudomonas exotoxin A |
12/23/2010 | WO2010148197A1 Inhibitors of influenza viruses replication |
12/23/2010 | WO2010147836A1 Combination therapies using antibacterial aminoglycoside compounds |
12/23/2010 | WO2010147684A1 Compositions for and methods of activating guanylyl cyclase c |
12/23/2010 | WO2010147472A1 Inhibition of nfk-b mediated virus replication with specific oligosaccharides |
12/23/2010 | WO2010147456A1 Inhibition of nfk-b mediated virus replication with specific oligosaccharides |
12/23/2010 | WO2010147397A2 New lactic acid bacteria having inhibitory effect on avian influenza virus infections and composition containing same |
12/23/2010 | WO2010147165A1 Rna virus infection inhibitor, method for inhibition of infection by rna virus, products for inhibition of infection by rna virus, and use as rna virus infection inhibitor |
12/23/2010 | WO2010147145A1 Anti-gram-negative bacteria agent |
12/23/2010 | WO2010147117A1 Peptide and use thereof |
12/23/2010 | WO2010147094A1 Compound having spiro-bonded cyclic group and use thereof |
12/23/2010 | WO2010147068A1 Substituted polycyclic carbamoylpyridone derivative |
12/23/2010 | WO2010146848A1 An antigenic peptide derived from influenza virus and a method for selecting anti-influenza virus antibody |
12/23/2010 | WO2010146622A1 Nfat signal inhibitor and calcineurin inhibitor |
12/23/2010 | WO2010146585A1 Tellurium-containing compounds for treating viral infections |
12/23/2010 | WO2010146257A1 Connection device for a submersible connector |
12/23/2010 | WO2010146125A1 Ester derivatives as competitive inhibitors of type ii dehydroquinase enzyme |
12/23/2010 | WO2010146113A1 Antifungal 1, 2, 4-triazolyl derivatives having a 5- sulfur substituent |
12/23/2010 | WO2010146112A1 Antifungal 1, 2, 4-triazolyl derivatives |
12/23/2010 | WO2010146111A1 Antifungal 1, 2, 4-triazolyl derivatives |
12/23/2010 | WO2010146067A1 Nodule specific medicago peptides having antimicrobial activity and pharmaceutical compositions containing the same |
12/23/2010 | WO2010145523A1 Compounds having activity of anti-hcv and uses thereof |
12/23/2010 | WO2010145205A1 Traditional chinese medicine composition for treating swine influenza, preparation method and use thereof |
12/23/2010 | WO2010145186A1 Peptide deformylase inhibitor containing 2,5-dihydropyrrole and synthesis method thereof |
12/23/2010 | WO2010145017A1 Stimulation of innate immunity with an antigen from bacterial origin |
12/23/2010 | WO2010144968A1 Casein derived protease inhibitory peptides |
12/23/2010 | WO2010144946A1 Method of determining response to treatment with immunomodulatory composition |
12/23/2010 | WO2010127264A3 HNF4α ANTAGONISTS AND METHODS OF USE |
12/23/2010 | WO2010119161A3 Antiepileptic, hypocholesterolemic and neuroprotective compound |
12/23/2010 | WO2010116336A8 Uses of red yeast rice in treating dengue virus infection |
12/23/2010 | WO2010084505A3 Stable topical formulation comprising voriconazole |
12/23/2010 | WO2010072770A3 Griseofulvin analogues for the treatment of cancer by inhibition of centrosomal clustering |
12/23/2010 | WO2009146555A8 Hiv integrase inhibitors from pyridoxine |
12/23/2010 | WO2009097394A3 Methods for modulating a population of myeloid-derived suppressor cells and uses thereof |
12/23/2010 | US20100324151 Methods and compositions for the treatment of infection or infectious colonization of the eyelid, ocular surface, skin or ear |
12/23/2010 | US20100324149 Methods And Compositions For Prevention And Treatment Of Inflammatory Disease, Autoimmune Disease, and Transplant Rejection |